Evidence map›Paper›PMID 42124899›Full record

ArticleCase reports in oncology

Septic Pulmonary Embolism due to Methicillin-Resistant

Aya Asano, Masafumi Seki, Wakako Inohana, Emi Mikami, Taeko Kurosawa, Ayako Nakame, Ayaka Sakakibara, Akihiro Fujimoto, Yuki Ichinose, Asami Nukui and 8 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Aya AsanoDepartment of Breast Oncology, Saitama Medical University Hospital, Hidaka, Japan.
Masafumi SekiDivision of Infectious Diseases and Infection Control, Saitama Medical University International Medical Center, Hidaka, Japan.
Wakako InohanaDepartment of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Japan.
Emi MikamiDepartment of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Japan.
Taeko KurosawaDepartment of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Japan.
Ayako NakameDepartment of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Japan.
Ayaka SakakibaraDepartment of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Japan.
Akihiro FujimotoDepartment of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Japan.
Yuki IchinoseDepartment of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Japan.
Asami NukuiDepartment of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Japan.
Hiroko ShimadaDepartment of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Japan.
Hideki YokogawaDepartment of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Japan.
Masahiro OharaDepartment of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Japan.
Kazuo MatsuuraDepartment of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Japan.
Hiroshi IshiguroDepartment of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Japan.
Takahiro HasebeDepartment of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Japan.
Akihiko OsakiDepartment of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Japan.
Toshiaki SaekiDepartment of Breast Oncology, International Medical Center, Saitama Medical University, Hidaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Septic pulmonary embolism (SPE) is a rare but serious complication in patients with cancer and is often difficult to distinguish from pulmonary metastases. Case Presentation: A woman in her 50s with a history of atopic dermatitis underwent left mastectomy and sentinel lymph node biopsy for hormone receptor-positive, HER2-negative breast cancer, followed by weekly adjuvant paclitaxel chemotherapy. After the seventh cycle, fever and left-sided neck pain developed. Physical examination revealed scalp folliculitis. Laboratory tests showed no leukopenia but revealed elevated C-reactive protein levels. Chest computed tomography (CT) demonstrated multiple subpleural nodules, initially suggestive of breast cancer metastasis; however, blood cultures obtained on admission yielded gram-positive cocci on the same day. Empirical intravenous antibiotic therapy was initiated and later deescalated to oral tedizolid after methicillin-resistant Conclusion: SPE should be considered in patients with breast cancer who develop fever and new pulmonary nodules during adjuvant chemotherapy, particularly in those with underlying skin conditions or chemotherapy-induced immunosuppression. Prompt recognition and targeted antibiotic therapy are essential for achieving favorable clinical outcomes.

Indexed as

Adjuvant chemotherapyBreast cancerMethicillin-resistant Staphylococcus aureus bacteremiaSeptic pulmonary embolism

Identifiers

PMID42124899
PMCPMC13160509

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.